Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

The effect of single-dose methylphenidate on the rate of error-driven learning in healthy males: a randomized controlled trial.

Howlett JR, Huang H, Hysek CM, Paulus MP.

Psychopharmacology (Berl). 2017 Nov;234(22):3353-3360. doi: 10.1007/s00213-017-4723-5. Epub 2017 Sep 1.

PMID:
28864865
2.

CYP2D6 function moderates the pharmacokinetics and pharmacodynamics of 3,4-methylene-dioxymethamphetamine in a controlled study in healthy individuals.

Schmid Y, Vizeli P, Hysek CM, Prestin K, Meyer Zu Schwabedissen HE, Liechti ME.

Pharmacogenet Genomics. 2016 Aug;26(8):397-401. doi: 10.1097/FPC.0000000000000231.

3.

Stress-Induced In Vivo Recruitment of Human Cytotoxic Natural Killer Cells Favors Subsets with Distinct Receptor Profiles and Associates with Increased Epinephrine Levels.

Bigler MB, Egli SB, Hysek CM, Hoenger G, Schmied L, Baldin FS, Marquardsen FA, Recher M, Liechti ME, Hess C, Berger CT.

PLoS One. 2015 Dec 23;10(12):e0145635. doi: 10.1371/journal.pone.0145635. eCollection 2015.

4.

Evaluation of drug incorporation into hair segments and nails by enantiomeric analysis following controlled single MDMA intakes.

Madry MM, Steuer AE, Hysek CM, Liechti ME, Baumgartner MR, Kraemer T.

Anal Bioanal Chem. 2016 Jan;408(2):545-56. doi: 10.1007/s00216-015-9130-3. Epub 2015 Oct 31.

PMID:
26521178
5.

Development of a high-speed MALDI-triple quadrupole mass spectrometric method for the determination of 3,4-methylenedioxymethamphetamine (MDMA) in oral fluid.

Poetzsch M, Steuer AE, Hysek CM, Liechti ME, Kraemer T.

Drug Test Anal. 2016 Feb;8(2):235-40. doi: 10.1002/dta.1810. Epub 2015 May 19.

PMID:
25990956
6.

Interactions between bupropion and 3,4-methylenedioxymethamphetamine in healthy subjects.

Schmid Y, Rickli A, Schaffner A, Duthaler U, Grouzmann E, Hysek CM, Liechti ME.

J Pharmacol Exp Ther. 2015 Apr;353(1):102-11. doi: 10.1124/jpet.114.222356. Epub 2015 Feb 5.

7.

Effects of methylphenidate and MDMA on appraisal of erotic stimuli and intimate relationships.

Schmid Y, Hysek CM, Preller KH, Bosch OG, Bilderbeck AC, Rogers RD, Quednow BB, Liechti ME.

Eur Neuropsychopharmacol. 2015 Jan;25(1):17-25. doi: 10.1016/j.euroneuro.2014.11.020. Epub 2014 Dec 4.

8.

Differential effects of MDMA and methylphenidate on social cognition.

Schmid Y, Hysek CM, Simmler LD, Crockett MJ, Quednow BB, Liechti ME.

J Psychopharmacol. 2014 Sep;28(9):847-56. doi: 10.1177/0269881114542454. Epub 2014 Jul 22.

PMID:
25052243
9.

Acute effects of 3,4-methylenedioxymethamphetamine and methylphenidate on circulating steroid levels in healthy subjects.

Seibert J, Hysek CM, Penno CA, Schmid Y, Kratschmar DV, Liechti ME, Odermatt A.

Neuroendocrinology. 2014;100(1):17-25. doi: 10.1159/000364879. Epub 2014 Jun 5.

PMID:
24903002
10.

Analytical interference of 4-hydroxy-3-methoxymethamphetamine with the measurement of plasma free normetanephrine by ultra-high pressure liquid chromatography-tandem mass spectrometry.

Dunand M, Donzelli M, Rickli A, Hysek CM, Liechti ME, Grouzmann E.

Clin Biochem. 2014 Aug;47(12):1121-3. doi: 10.1016/j.clinbiochem.2014.04.003. Epub 2014 Apr 13.

PMID:
24731790
11.

MDMA effects consistent across laboratories.

Kirkpatrick MG, Baggott MJ, Mendelson JE, Galloway GP, Liechti ME, Hysek CM, de Wit H.

Psychopharmacology (Berl). 2014 Oct;231(19):3899-905. doi: 10.1007/s00213-014-3528-z. Epub 2014 Mar 15.

12.

Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination.

Hysek CM, Simmler LD, Schillinger N, Meyer N, Schmid Y, Donzelli M, Grouzmann E, Liechti ME.

Int J Neuropsychopharmacol. 2014 Mar;17(3):371-81. doi: 10.1017/S1461145713001132. Epub 2013 Oct 8.

PMID:
24103254
13.

MDMA enhances emotional empathy and prosocial behavior.

Hysek CM, Schmid Y, Simmler LD, Domes G, Heinrichs M, Eisenegger C, Preller KH, Quednow BB, Liechti ME.

Soc Cogn Affect Neurosci. 2014 Nov;9(11):1645-52. doi: 10.1093/scan/nst161. Epub 2013 Oct 4.

14.

Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans: Lost in translation.

Hysek CM, Schmid Y, Rickli A, Liechti ME.

Br J Pharmacol. 2013 Nov;170(6):1273-5. doi: 10.1111/bph.12398. No abstract available.

15.

α₁-Adrenergic receptors contribute to the acute effects of 3,4-methylenedioxymethamphetamine in humans.

Hysek CM, Fink AE, Simmler LD, Donzelli M, Grouzmann E, Liechti ME.

J Clin Psychopharmacol. 2013 Oct;33(5):658-66. doi: 10.1097/JCP.0b013e3182979d32.

PMID:
23857311
16.

Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex.

Hysek CM, Liechti ME.

Psychopharmacology (Berl). 2012 Dec;224(3):363-76. doi: 10.1007/s00213-012-2761-6. Epub 2012 Jun 15.

PMID:
22700038
17.

Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study.

Hysek CM, Simmler LD, Nicola VG, Vischer N, Donzelli M, Krähenbühl S, Grouzmann E, Huwyler J, Hoener MC, Liechti ME.

PLoS One. 2012;7(5):e36476. doi: 10.1371/journal.pone.0036476. Epub 2012 May 4.

18.

Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans.

Hysek C, Schmid Y, Rickli A, Simmler LD, Donzelli M, Grouzmann E, Liechti ME.

Br J Pharmacol. 2012 Aug;166(8):2277-88. doi: 10.1111/j.1476-5381.2012.01936.x.

19.

MDMA enhances "mind reading" of positive emotions and impairs "mind reading" of negative emotions.

Hysek CM, Domes G, Liechti ME.

Psychopharmacology (Berl). 2012 Jul;222(2):293-302. doi: 10.1007/s00213-012-2645-9. Epub 2012 Jan 27.

PMID:
22277989
20.

Effects of the α₂-adrenergic agonist clonidine on the pharmacodynamics and pharmacokinetics of 3,4-methylenedioxymethamphetamine in healthy volunteers.

Hysek CM, Brugger R, Simmler LD, Bruggisser M, Donzelli M, Grouzmann E, Hoener MC, Liechti ME.

J Pharmacol Exp Ther. 2012 Feb;340(2):286-94. doi: 10.1124/jpet.111.188425. Epub 2011 Oct 27.

21.

Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects.

Simmler LD, Hysek CM, Liechti ME.

J Clin Endocrinol Metab. 2011 Sep;96(9):2844-50. doi: 10.1210/jc.2011-1143. Epub 2011 Jun 29.

PMID:
21715530
22.

The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans.

Hysek CM, Simmler LD, Ineichen M, Grouzmann E, Hoener MC, Brenneisen R, Huwyler J, Liechti ME.

Clin Pharmacol Ther. 2011 Aug;90(2):246-55. doi: 10.1038/clpt.2011.78. Epub 2011 Jun 15.

PMID:
21677639
23.

Effects of a beta-blocker on the cardiovascular response to MDMA (Ecstasy).

Hysek CM, Vollenweider FX, Liechti ME.

Emerg Med J. 2010 Aug;27(8):586-9. doi: 10.1136/emj.2009.079905. Epub 2010 Apr 8.

Supplemental Content

Loading ...
Support Center